Navigation Links
Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
Date:10/22/2007

BOULDER, Colo., Oct. 22 /PRNewswire/ -- Sciona, Inc., a leader in the science of nutrigenetics, today announced the results of a pivotal study published by Nutrition Journal, which demonstrates substantial advances in long term weight management and blood glucose levels as a result of personalizing patients' diets based on their genetic information (nutrigenetics). In the first study to demonstrate the efficacy of applying nutrigenetics to long term weight management, researchers found significant improvement in long term (more than 300 days) weight management for individuals whose nutrient requirements were tailored to individual variations in the genes known to affect nutrient metabolism and transport. Each subject's genetic profile was developed by the use of Sciona's Mycellf Kit.

The comprehensive 3 year study examined 93 individuals with a history of weight loss failures. In an effort to answer whether the application of genetic information could improve sustained weight management, one test group was genetically screened for (24) separate variants in (19) individual genes specifically know to be related to metabolism. A second control group did not receive the genetic screening. The groups were matched on characteristics such as age, gender, frequency of clinical visits and Body Mass Index (BMI), during their initial clinical visit. After monitoring patients between the fixed ranges of 100 - 300 days, the BMI and the fasting blood glucose levels were compared and contrasted within the test population.

Results conclusively showed that after 300 days, individuals in the genetic testing group were more likely to have maintained weight reduction and reduced glucose levels than those of the control group, which had not been genetically screened. In the final analysis, 73% of those in the nutrigenetic group maintained weight reduction compared to only 32% of those in the control group. Among patients with a fasting blood glucose of greater than 10
'/>"/>

SOURCE Sciona, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/22/2014)... , Dec. 22, 2014 Apnea Sciences ( ... offices in Aliso Viejo , California.  ... to the tremendous growth and worldwide expansion, a new ... patented SnoreRx, the anti snore cure have exceeded our ... "We are now in 23 countries and will ...
(Date:12/22/2014)... 22, 2014   TRU-D SmartUVC LLC, producers ... robot, announced today that the General Services Administration has ... 2019.   This newly formed agreement will ... of government purchasers, including Department of Veteran Affairs and ... Security contacts purchasing solutions for the Ebola effort in ...
(Date:12/22/2014)... 2014  ConvaTec, a privately-held medical products and technologies ... Interim Chief Executive Officer of the company, effective December ... Berger .  "The Board of Directors of ConvaTec thanks ... the past three years," said Magnus Lundberg , ... confident that the company is well positioned for the ...
Breaking Medicine Technology:TRU-D SmartUVC LLC Awarded General Services Administration Contract to Expand Government Customer Base 2ConvaTec Names Paul Moraviec Interim CEO Effective December 22, 2014 2
... Roxane Laboratories, Inc. announced today the approval of its Abbreviated ... by the U.S. Food and Drug Administration. The product is available ... nationwide. , , , ... Laboratories, Naratriptan Tablets USP are AB rated to AMERGE® (naratriptan hydrochloride) ...
... SPRING, Md. , July 8 People who use the malaria drug Qualaquin to treat ... , , ... (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) , ... and Drug Administration (FDA) says they may be at risk for serious and life-threatening effects. , ...
Cached Medicine Technology:Roxane Laboratories, Inc. Announces the Launch of Naratriptan Tablets USP 2FDA Consumer Health Information: Using Malaria Medication For Leg Cramps Is Risky 2
(Date:12/24/2014)... 24, 2014 The Healthy Home Company has ... raise families. In-Vest USA is dedicated to ... – our first responders. Today, these two organizations have joined ... providing them with body armor through In-Vest’s USA’s Bless the ... that happened this past week in New York. ...
(Date:12/24/2014)... There’s a lot going on with The Affordable Care ... control of the Senate as well as the House, a ... lawsuit has been brought against President Obama by the House, ... have resulted in changes to the law without the approval ... place to weigh the validity of subsidies provided to low ...
(Date:12/24/2014)... “ Relax Melodies ” was featured on NewsWatch ... latest and coolest mobile applications on the iOS, Android, ... and host of NewsWatch, conducted the app review and ... they can fall asleep. , According to the National ... some sort of difficulty sleeping. Since that’s a huge ...
(Date:12/24/2014)... 2014 Dr. Ronald Receveur, a ... placing dental implants in a day, has ... of overusing teeth-whitening treatments. , In his blog ... Dr. Receveur writes that overusing teeth-whitening treatments can lead ... to enamel. , “Because teeth-whitening treatments are ...
(Date:12/24/2014)... year, more than one-third of the more than 10,000 ... extreme heat conditions, according to recent federal statistics. ... the leading cause of heat-related illness among Americans, but ... infections, also put older people at higher risk for ... help health care systems anticipate and perhaps prevent many ...
Breaking Medicine News(10 mins):Health News:The Healthy Home Company and In-Vest USA Team Up to Save the Lives of Law Enforcement 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 2Health News:Steven Gerst MD Discusses How, Amid Political Opposition, Court Challenges, and a New Open Enrollment Period, the Affordable Care Act still Relies on Health Informatics 3Health News:An Application to Help with Insomnia was Featured on NewsWatch Television on December 19, 2014 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 2Health News:New Albany Dentist Weighs In On New Trend of Overbleaching Teeth 3Health News:Heat Stroke, Kidney Failure Help Drive Illnesses From Extreme Heat 2
... Key New Products Including Completing CE Mark, ... -, TSX Venture Exchange: NVC,VANCOUVER, April ... that it has completed a previously announced non-brokered private ... of $0.21 per unit for aggregate gross proceeds of ...
... Copenhagen, Denmark, Friday 24 April: HIV positive and ... transplant, according to new research presented today at EASL ... the Study of Liver in Copenhagen, Denmark. , The ... 1 and 5 years between HIV negative and HIV ...
... highest standards in the security industry , ... Freeport, ... Inc. is pleased to announce it has once again been awarded ... Alarm Association (CSAA)., , , , ,There are approximately 2,700 central ...
... community and helps individuals with vision care and restoration. , ... ... Christian is an affluent, prestigious, private high school, nestled in the ... their efforts and dedication toward educating America,s youth, by donating several ...
... much as younger ones, , , THURSDAY, April 23 (HealthDay ... older than 50 -- even if they,ve had several ... level of risk as younger women, European researchers contend. ... repeating smear tests in women 60 to 65 years ...
... MINNEAPOLIS, April 23 As federal policymakers pursue healthcare ... health promotion and disease prevention will be critically evaluated. ... more than 40 of North America,s top medical schools ... original scientific research in the area of integrative medicine. ...
Cached Medicine News:Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 2Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 3Health News:HIV positive and HIV negative patients have similar survival rates following liver transplant 2Health News:New York Merchants Protective Co. Renews CSAA Five Diamond Certification 2Health News:New York Merchants Protective Co. Renews CSAA Five Diamond Certification 3Health News:Khanna Institute Supports Oaks Christian School's Annual Fundraiser 2Health News:Don't Lower Age for Cervical Cancer Test, Study Urges 2Health News:Advancements in Integrative Medicine Research to Be Evaluated by Scientists From Leading International Academic Health Centers 2
The CGIL iridectomy contact glass was designed by Riquin, Fankhauser et al. to perform full thickness peripheral laser iridectomies....
The CGVL vitrectomy contact glass was designed by Rol, Fankhauser et al. for photodisruptive YAG laser procedures in the posterior vitreous....
For newly born children 10 mm internal diameter of the cornea part. Designed to work with argon/YAG Lasers....
... uses a classical distance-independent measuring principle which ... The size of the mire image is ... and the measured object; 2. The resulting ... the Ophthalmometer and the measured object; 3. ...
Medicine Products: